Hence, transcriptional modulation of the NRG1 pathway might be one of the mechanisms through which BRD4 plays a role in ovarian cancer patients’ response to chemotherapy, however, further studies are required to validate such mechanism. The gene discussed is BRD4; the disease is ovarian carcinoma.